OrthoScan closes $7.5M in financing

OrthoScan, a medical device company, has closed a $7.5 million Series B financing led by River Cities Capital Funds.

Additional participants include existing investors Aphelion Capital, California Technology Ventures and a group of accredited private individuals, according to the Scottsdale, Ariz.-based company.

In connection with the financing, Carter McNabb, managing director of River Cities, has joined OrthoScan’s board, OrthoScan said.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.